Artelo Biosciences (ARTL) Current Leases (2021 - 2025)
Artelo Biosciences (ARTL) posted quarterly Current Leases of $40000.0 for Q4 2025, up 14.29% year-over-year from $35000.0 in Q4 2024, and up 2.56% quarter-over-quarter from $39000.0 in Q3 2025.
Artelo Biosciences (ARTL) Current Leases (2021 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Current Leases for 5 consecutive years, with $40000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Leases rose 14.29% year-over-year to $40000.0; the TTM figure through Dec 2025 stood at $40000.0 (up 14.29% YoY), while the FY2025 annual figure was $40000.0, up 14.29% from the prior year.
- Current Leases grew to $40000.0 in Q4 2025 per ARTL's latest filing, from $39000.0 in the prior quarter.
- Across five years, Current Leases topped out at $45000.0 in Q2 2022 and bottomed at $7000.0 in Q1 2022.
- Historically, Current Leases has averaged $33500.0 across 5 years, with a median of $34500.0 in 2023.
- On a YoY basis, Current Leases climbed as much as 428.57% in 2023 and fell as far as 42.5% in 2023.
- Artelo Biosciences' Current Leases stood at $31000.0 in 2021, then climbed by 29.03% to $40000.0 in 2022, then sank by 42.5% to $23000.0 in 2023, then surged by 52.17% to $35000.0 in 2024, then increased by 14.29% to $40000.0 in 2025.
- Business Quant data shows ARTL's Current Leases at $40000.0 in Q4 2025, $39000.0 in Q3 2025, and $36000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Artelo Biosciences | 111,698.23 | -488,301.77 | - | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 36,000.00 |
| Dec 31, 2024 | 35,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 33,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 32,000.00 |
| Jun 30, 2023 | 34,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 7,000.00 |
| Nov 30, 2021 | 31,000.00 |
| Aug 31, 2021 | 28,000.00 |